Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expressions [1]. This evidence concerns the gene PGR and triple-negative breast carcinoma.